Conservative management of placenta previa‐percreta with bladder invasion: A case report
Rattachement africain : ir. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Key Clinical Message: Placenta previa, accompanied by placenta percreta, which involves invasion of the bladder, presents a significant risk of excessive bleeding during and after delivery. This case highlights that prophylactic embolization, conservative surgery, and careful monitoring offer an effective approach to avoid hysterectomy in cases of placenta percreta with adjacent organ involvement. Abstract: Placenta previa complicated by placenta percreta is associated with a high risk of massive intra and post-partum hemorrhage. We present a case of a 35-year-old woman (G2 P1) who was referred to the Akbar-Abadi hospital at 13 weeks of gestation. Color Doppler ultrasound indicated complete placenta previa-percreta with bladder invasion. After induction of fetal demise, bilateral uterine and bladder artery endovascular embolization was conducted for the patient. After 48 h, under ultrasound guidance, surgical resection of residual percreta tissue was conducted as much as possible. Eight weeks later, a follow-up sonography showed the minimum residual placenta tissue and she regained menstrual cycles after 2 months. This case indicated that the combination of prophylactic embolization, conservative surgical management with placenta left in situ, and follow-up with serial color Doppler monitoring, is an optimum method to avoid hysterectomy in placenta percreta patient with adjacent organ invasion.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Conservative management of placenta previa‐percreta with bladder invasion: A case report
- Date Crossref
- 01/05/2024
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Iran University of Medical Sciences Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Tehran University of Medical Sciences Vali‐E‐Asr Reproductive Health Research Center Family Health Research Institute pays non établi dans la noticeUniversité ou école supérieure
-
Firoozgar General Hospital pays non établi dans la noticeÉtablissement de santé
-
Unit (ShACRDU) School of Medicine Shahid Akbarabadi Clinical Research Development pays non établi dans la noticeUniversité ou école supérieure
Department of Obstetrics and Gynecology — Iran University of Medical Sciences, Vali‐E‐Asr Reproductive Health Research Center Family Health Research Institute — Tehran University of Medical Sciences et Firoozgar General Hospital, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.